Podcasts

Articles

Webinars

Peer-Reviewed

Videos

The annual meeting of the American Academy of Ophthalmology includes subspecialty meetings focusing on the cornea, glaucoma, pediatric ophthalmology, oculofacial plastic surgery, refractive surgery, the retina, and uveitis.

AAO: American Academy of Ophthalmology

Posters presented at the American Academy of Ophthalmology 2021 annual meeting showed that even patients with mild inflammation with their thyroid eye disease benefitted from teprotumumab and that real-world adherence was consistent with the pivotal clinical trials.

Teprotumumab Benefits Patients With Mild Inflammation and Real-world Adherence Remains High

Among many presentations during a hot topics session at the American Academy of Ophthalmology 2021 annual meeting, speakers discussed the first FDA approved therapy for thyroid eye disease and the latest in enhanced monofocal intraocular lenses (IOLs).

Teprotumumab, Enhanced Monofocal IOLs Among Hot Topics at AAO 2021

David Ramsey, MD, PhD, MPH, explains findings from a study on telehealth use among patients with diabetes in Massachusetts. 

Dr David Ramsey Describes the Impact of Telehealth on Completed Eye Examinations for Diabetic Retinopathy 

James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, outlines the benefits and challenges of transferring ophthalmic care to outpatient facilities. 

Dr James Auran Discusses the Transition of Ophthalmic Care to an Outpatient Specialty

Anne Barmettler, MD, an associate professor of ophthalmology, visual sciences, and plastic surgery at Montefiore Medical Center discusses patient feedback on Tepezza (teprotumumab) for thyroid eye disease. 

Dr Anne Barmettler Describes Patient Uptake of Teprotumumab 

The field of ophthalmology had already been moving toward telehealth and artificial intelligence (AI) before the COVID-19 pandemic, but these changes are being accelerated now, making it crucial for ophthalmologists to learn to adapt.

Ophthalmology at Crossroads for Information Technology, AI

Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, discusses how a patient’s age can affect their glaucoma symptoms and treatment. 

Dr Leon Herndon Explains the Role of Age in Primary Open-Angle Glaucoma 

Aaron Lee, MD, an associate professor of ophthalmology at University of Washington, describes how artificial intelligence (AI) is used in ophthalmology now and how it could be utilized in the future. 

Dr Aaron Lee Discusses the Future of AI in Ophthalmology

Emergency department utilization for nonemergent ophthalmic conditions is on the rise in the United States, but presentation types vary significantly based on patient demographics, according to 2 posters presented at the American Academy of Ophthalmology (AAO) 2021 meeting.

Posters at AAO 2021 Analyze ED Utilization for Nonemergency Ophthalmic Conditions

Victoria Ly, MD, MPH, explains the results of her study on follow-up among students in Arkansas who failed their vision screening tests. 